SynbiTECH Live, 6th July 2020

SARS-CoV-2 and Synthetic Biology: Opportunities for Detection and Treatment

SynbiTECH 2020 Webinar - SynbiTECH Live - 6 July 2020
15.00 - 17.00 UK
10.00 - 12.00 US EST
07.00 - 09.00 US PT

The coronavirus pandemic has had a devastating effect on international public health and the world economy. Our first SynbiTECH Live webinar will address the role of synthetic biology in the detection and treatment of COVID-19 and its potential role in combatting future pandemics.

We will review the ongoing pandemic from both UK and US standpoints, with insights from  leading global experts in epidemiology, infectious diseases and vaccine technology. This will be followed by an overview of the role of synthetic biology in the pandemic, how it has been effectively applied to testing for the virus, and its potential for the future.

We will be joined by medical scientists and clinicians directly involved in the epidemic who will share their experiences and learnings from the last few months.

Register for webinar

Webinar Programme

Introduction and webinar overview

15.00 – 15.05

Professors Paul Freemont and Richard Kitney, Co-Directors of SynbiCITE


Coronavirus global pandemic

15.05 – 15.20

Speaker to be confirmed


Coronavirus in the US

15.20 – 15.35

Rick Johnson, CEO and founder of Global Helix LLC


Research overview

15.35 – 15.50

Professor Wendy Barclay, Action Medical Research Chair, Imperial College London


Overview of synthetic biology and its role

15.50 – 16.10

Richard Kitney

  • DNA reading and writing
  • The design, build, test and learn paradigm (DBTL)
  • Systematic bio design and the development of workflows
  • The development of laboratory automation and biofoundries

The use of biofoundries and synthetic biology for testing

16.10 – 16.30 

Paul Freemont

  • The role of biofoundries in national and international emergencies
  • The advantage of synthetic biology based automated workflows
  • Repurposing automated workflows in the London Biofoundry for COVID-19 testing
    • Reagent agnostic drop-in solutions to existing diagnostic workflows
    • Novel NextGen CRISPR / LAMP workflows for COVID testing

Synthetic biology and SARS-CoV-2 treatment

16.30 – 16.45 

Speaker to be confirmed


Discussion and conclusions

16.45 – 17.00

Paul Freemont and Richard Kitney

Register for the Webinar

Participation in the webinar is free of charge. To register your attendance, please complete the form and we will send you joining information.
Submit your question in advance to be answered during SynbiTECH Live
Opt-in to receive our latest updates and news of upcoming events.